Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Invesco DWA Healthcare Momentum ETF (PTH) belongs to the US Health Care segment. Virtus LifeSci Biotech Products ETF (BBP) is part of the Tomorrow's Treatments segment. Both ETFs have the same top 3 sector exposures: and Health Care. PTH is less expensive with a Total Expense Ratio (TER) of 0.72%, versus 0.79% for BBP. PTH is down -0.94% year-to-date (YTD) with -$2M in YTD flows. BBP performs better with 7.12% YTD performance, and +$4M in YTD flows. Run a side-by-side ETF comparison of PTH and BBP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PTH BBP | +0.87%+3.56% | -2.99%+10.97% | -0.94%+7.12% | +31.67%+43.58% | +40.70%+78.58% | -4.17%+59.76% |
| Flows | PTH BBP | -+$4M | -$2M+$16M | -$2M+$4M | -$15M+$19M | -$92M+$19M | -$495M+$9M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PTH BBP | +21.14%+24.63% | +24.53%+25.52% | +24.42%+23.63% | +25.61%+26.14% |
| Max drawdown | PTH BBP | -7.58%-7.42% | -16.12%-17.97% | -29.24%-25.54% | -50.10%-38.24% |
| Max drawdown duration | PTH BBP | 86d32d | 183d106d | 271d292d | 1650d915d |
PTH | BBP | |
Last sale 3/11/2026 at 1:30 PM | $48.86 | $84.32 |
| Previous close 03/10/2026 | $49.20 | $85.25 |
| Consolidated volume 03/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
PTH | BBP | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
PTH | BBP | |
|---|---|---|
| Last price | $48.86 | $84.32 |
| 1D performance | -0.70% | -1.10% |
| AuM | $122.13 M | $51.26 M |
| E/R | 0.72% | 0.79% |
PTH | BBP | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Invesco | VIRTUS Investment Partners |
| Benchmark | Dorsey Wright Healthcare Technical Leaders Index | LifeSci Biotechnology Products Index |
| N° of holdings | 46 | 58 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | October 12, 2006 | December 16, 2014 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
